MADRIGAL PHARMACEUTICALS, INC. 4

Director James M. Daly received RSUs over 454 Madrigal Pharmaceuticals common shares and a 766-share stock option at a $499.86 strike as part of equity compensation.

On June 17, 2026, James M. Daly, a director of Madrigal Pharmaceuticals, Inc., received equity compensation consisting of 454 shares of common stock underlying a restricted stock unit (RSU) award and a stock option for 766 shares with an exercise price of $499.86 per share, both vesting in full on the earlier of June 17, 2027 or the date of the issuer’s 2027 annual stockholders’ meeting, contingent on continued service. Following these grants, Daly directly beneficially owns 3,081 shares of common stock, including the newly granted RSUs, and 766 stock options that are currently unexercised, reflecting routine director compensation rather than an open-market purchase or sale.

Filing Facts

CIK

1157601

Ticker

MDGL

Form

4

Source Type

sec

Accession

0001628280-26-044307

Alert Tier

5